
    
      The aim of the present study is to evaluate the safety of OLEANDER 4X HPUS. This protocol
      outlines a study involving Healthy volunteers. Up to 45 volunteers will be recruited in the
      USA.

      Second ARM, sub-study: As a second arm of this study, a random double blind,
      placebo-controlled pharmacokinetics study in healthy volunteers. Briefly, 15 healthy
      volunteers who meet the same eligibility criteria and agree to participation in the study
      will be placed on one, two, or 4 doses (1 mL per dose) of OLEANDER 4X HPUS one time.

      This is effectively three ascending doses in 4 subjects on OLEANDER 4X HPUS, compared to the
      placebo (1 subject).
    
  